Factors associated with hyperkalemia in patients with CKD, in addition to reduced kidney function, include concomitant medication use (e.g., renin–angiotensin–aldosterone system inhibitors and potassium-sparing diuretics), and comorbidities (e.g., diabetes and cardiovascular disease) [23, 24]. The gene discussed is REN; the disease is diabetes mellitus.